Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Ellermann

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Pharmaceutics|March 27, 2025
Divergent Electrophysiologic Effects of Sacubitril in Digitalis- and Pinacidil-Related Shortened Repolarization: Experimental Evidence for Harmful Effects of Digitalis GlycosidesChristian Ellermann, Carlo Mengel, Julian Wolfes, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic DrugsChristian Ellermann, Carlo Mengel, Julian Wolfes, et al.
International Journal of Cardiology|June 14, 2017
Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndromeChristian Ellermann, Julian Wolfes, Simon Kochhäuser, et al.
Cardiovascular Toxicology|December 6, 2018
Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated HeartsChristian Ellermann, Julian Wolfes, Dirk Puckhaber, et al.
International Journal of Cardiology|November 19, 2016
Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedaroneGerrit Frommeyer, Dirk Puckhaber, Christian Ellermann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 7, 2017
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, André Mittelstedt, Julian Wolfes, et al.
Clinical and Experimental Pharmacology & Physiology|May 31, 2017
Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- SyndromeGerrit Frommeyer, Jan Weller, Christian Ellermann, et al.
Cardiovascular Toxicology|June 6, 2020
Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit HeartsJulian Wolfes, Christian Ellermann, Sophie Burde, et al.
Pharmacology|September 29, 2022
Electrophysiological Safety Profile of Antiestrogenic Therapies in the Isolated Rabbit HeartJulian Wolfes, Christian Ellermann, Lina Marie Kirchner, et al.
Journal of Cardiovascular Electrophysiology|June 7, 2018
Change of sensing vector in the subcutaneous ICD during follow-up and after device replacementMarkus Bettin, Benjamin Rath, Christian Ellermann, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Pharmaceutics|March 27, 2025
Divergent Electrophysiologic Effects of Sacubitril in Digitalis- and Pinacidil-Related Shortened Repolarization: Experimental Evidence for Harmful Effects of Digitalis GlycosidesChristian Ellermann, Carlo Mengel, Julian Wolfes, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic DrugsChristian Ellermann, Carlo Mengel, Julian Wolfes, et al.
International Journal of Cardiology|June 14, 2017
Divergent antiarrhythmic effects of resveratrol and piceatannol in a whole-heart model of long QT syndromeChristian Ellermann, Julian Wolfes, Simon Kochhäuser, et al.
Cardiovascular Toxicology|December 6, 2018
Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated HeartsChristian Ellermann, Julian Wolfes, Dirk Puckhaber, et al.
International Journal of Cardiology|November 19, 2016
Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedaroneGerrit Frommeyer, Dirk Puckhaber, Christian Ellermann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 7, 2017
The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart modelGerrit Frommeyer, André Mittelstedt, Julian Wolfes, et al.
Clinical and Experimental Pharmacology & Physiology|May 31, 2017
Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- SyndromeGerrit Frommeyer, Jan Weller, Christian Ellermann, et al.
Cardiovascular Toxicology|June 6, 2020
Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit HeartsJulian Wolfes, Christian Ellermann, Sophie Burde, et al.
Pharmacology|September 29, 2022
Electrophysiological Safety Profile of Antiestrogenic Therapies in the Isolated Rabbit HeartJulian Wolfes, Christian Ellermann, Lina Marie Kirchner, et al.
Journal of Cardiovascular Electrophysiology|June 7, 2018
Change of sensing vector in the subcutaneous ICD during follow-up and after device replacementMarkus Bettin, Benjamin Rath, Christian Ellermann, et al.
Pageof 11